Arch Venture Management’s CERo Therapeutics CERO Stock Holding History

Arch Venture Management’s Portfolio CERO Stock Details CERO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,389	Closed	-$114K	–	10
2025 Q3	$114K	Hold	22,389	–	–	0.02%	9
2025 Q2	$216K	Buy	22,389 +21,284	+1,926%	+$265K	0.07%	11
2025 Q1	$16.1K	Sell	1,105 -3,592	-76%	-$142K	0.01%	9
2024 Q4	$564K	Buy	4,697 +3,975	+551%	+$927K	0.24%	9
2024 Q3	$135K	Hold	722	–	–	0.05%	9
2024 Q2	$432K	Hold	722	–	–	0.16%	9
2024 Q1	$4.43M	Buy	+722	New	+$8.08M	5.52%	6

Arch Venture Management's CERO Position: Q4 2025 in Review

Arch Venture Management sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 22,389 shares — an estimated $114K sold.

Arch Venture Management first reported a position in CERO in Q1 2024 and held it in 7 quarters. The position peaked at $4.43M in Q1 2024. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

Arch Venture Management reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
Arch Venture Management sold 22,389 CERo Therapeutics shares in Q4 2025, an estimated $114K.
Arch Venture Management first reported a position in CERo Therapeutics in Q1 2024 and held it in 7 quarters.
Arch Venture Management's CERo Therapeutics position peaked at $4.43M in Q1 2024.
0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on Arch Venture Management's 13F filing for Q4 2025, filed 17 Feb 2026.